Verition Fund Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-75,386
Closed -$7.16M 1467
2019
Q2
$6.97M Buy
75,386
+73,240
+3,413% +$6.95M 0.2% 85
2019
Q1
$202K Sell
2,146
-52,286
-96% -$4.57M 0.01% 966
2018
Q4
$3.49M Sell
54,432
-4,411
-7% -$326K 0.25% 82
2018
Q3
$5.27M Buy
58,843
+10,374
+21% +$917K 0.19% 89
2018
Q2
$3.85M Buy
48,469
+32,223
+198% +$2.68M 0.24% 80
2018
Q1
$1.45M Buy
+16,246
New +$1.56M 0.11% 232
2017
Q1
Sell
-5,392
Closed -$624K 1630
2016
Q4
$624K Sell
5,392
-25,438
-83% -$2.83M 0.05% 448
2016
Q3
$3.22M Buy
30,830
+15,618
+103% +$1.69M 0.35% 44
2016
Q2
$1.5M Buy
15,212
+9,364
+160% +$969K 0.19% 112
2016
Q1
$585K Buy
5,848
+1,873
+47% +$193K 0.09% 277
2015
Q4
$476K Buy
+3,975
New +$460K 0.09% 205
2014
Q4
Sell
-5,726
Closed -$543K 843
2014
Q3
$543K Buy
+5,726
New +$517K 0.08% 217
2014
Q2
Sell
-12,902
Closed -$901K 885
2014
Q1
$901K Buy
+12,902
New +$1.02M 0.14% 105
2013
Q4
Sell
-2,994
Closed -$230K 794
2013
Q3
$230K Sell
2,994
-2,002
-40% -$140K 0.03% 413
2013
Q2
$292K Buy
+4,996
New +$301K 0.05% 364

Other funds holding CELG

Verition Fund Management's CELG Position: Q3 2019 in Review

Verition Fund Management sold out of Celgene Corp (CELG) in Q3 2019, closing a stake of 75,386 shares — an estimated $7.16M sold.

Verition Fund Management first reported a position in CELG in Q2 2013 and held it in 15 quarters. The position peaked at $6.97M in Q2 2019. 1,245 funds tracked by Wall St. Rank hold CELG as of Q3 2019.

  • Verition Fund Management reported no remaining Celgene Corp position as of Q3 2019 after selling out during the quarter.
  • Verition Fund Management sold 75,386 Celgene Corp shares in Q3 2019, an estimated $7.16M.
  • Verition Fund Management first reported a position in Celgene Corp in Q2 2013 and held it in 15 quarters.
  • Verition Fund Management's Celgene Corp position peaked at $6.97M in Q2 2019.
  • 1,245 funds tracked by Wall St. Rank held Celgene Corp as of Q3 2019.

Based on Verition Fund Management's 13F filing for Q3 2019, filed 14 Nov 2019.